153 related articles for article (PubMed ID: 10894460)
1. Aerosolized medications for altering lung surface active properties.
MacIntyre NR
Respir Care; 2000 Jun; 45(6):676-83. PubMed ID: 10894460
[TBL] [Abstract][Full Text] [Related]
2. Surfactant replacement therapy for adult respiratory distress syndrome in children.
Evans DA; Wilmott RW; Whitsett JA
Pediatr Pulmonol; 1996 May; 21(5):328-36. PubMed ID: 8726159
[TBL] [Abstract][Full Text] [Related]
3. Biophysical behavior of lung surfactant: implications for respiratory physiology and pathophysiology.
Notter RH
Semin Perinatol; 1988 Jul; 12(3):180-212. PubMed ID: 3041603
[TBL] [Abstract][Full Text] [Related]
4. Aerosolized surfactants.
Mazela J; Merritt TA; Finer NN
Curr Opin Pediatr; 2007 Apr; 19(2):155-62. PubMed ID: 17496758
[TBL] [Abstract][Full Text] [Related]
5. Innovation in surfactant therapy II: surfactant administration by aerosolization.
Pillow JJ; Minocchieri S
Neonatology; 2012; 101(4):337-44. PubMed ID: 22940623
[TBL] [Abstract][Full Text] [Related]
6. Inactivation of pulmonary surfactant and the treatment of acute lung injuries.
Taeusch HW; Keough KM
Pediatr Pathol Mol Med; 2001; 20(6):519-36. PubMed ID: 11699577
[TBL] [Abstract][Full Text] [Related]
7. Early versus delayed surfactant administration in extremely premature neonates with respiratory distress syndrome ventilated by high-frequency oscillatory ventilation.
Plavka R; Kopecký P; Sebron V; Leiská A; Svihovec P; Ruffer J; Dokoupilová M; Zlatohlávková B; Janus V; Keszler M
Intensive Care Med; 2002 Oct; 28(10):1483-90. PubMed ID: 12373475
[TBL] [Abstract][Full Text] [Related]
8. Ultrasonic nebulized in comparison with instilled surfactant treatment of preterm lambs.
Henry MD; Rebello CM; Ikegami M; Jobe AH; Langenback EG; Davis JM
Am J Respir Crit Care Med; 1996 Aug; 154(2 Pt 1):366-75. PubMed ID: 8756808
[TBL] [Abstract][Full Text] [Related]
9. Aerosolized versus instilled exogenous surfactant in a nonuniform pattern of lung injury.
Lewis JF; McCaig L
Am Rev Respir Dis; 1993 Nov; 148(5):1187-93. PubMed ID: 8239152
[TBL] [Abstract][Full Text] [Related]
10. Pulmonary surfactant: functions, abnormalities and therapeutic options.
Frerking I; Günther A; Seeger W; Pison U
Intensive Care Med; 2001 Nov; 27(11):1699-717. PubMed ID: 11810113
[TBL] [Abstract][Full Text] [Related]
11. Aerosolized and instilled surfactant therapies for acute lung injury caused by intratracheal endotoxin in rats.
Tashiro K; Yamada K; Li WZ; Matsumoto Y; Kobayashi T
Crit Care Med; 1996 Mar; 24(3):488-94. PubMed ID: 8625639
[TBL] [Abstract][Full Text] [Related]
12. The role of surfactant treatment in preterm infants and term newborns with acute respiratory distress syndrome.
Wirbelauer J; Speer CP
J Perinatol; 2009 May; 29 Suppl 2():S18-22. PubMed ID: 19399004
[TBL] [Abstract][Full Text] [Related]
13. [Preterm and term infants with acute respiratory distress syndrome (ARDS): what is the role of surfactant substitution?].
Wirbelauer J; Thomas W; Speer CP
Z Geburtshilfe Neonatol; 2009 Apr; 213(2):33-41. PubMed ID: 19319791
[TBL] [Abstract][Full Text] [Related]
14. Open lung ventilation preserves the response to delayed surfactant treatment in surfactant-deficient newborn piglets.
van Veenendaal MB; van Kaam AH; Haitsma JJ; Lutter R; Lachmann B
Crit Care Med; 2006 Nov; 34(11):2827-34. PubMed ID: 17006360
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of surfactant treatment strategies after prolonged graft storage in lung transplantation.
Novick RJ; MacDonald J; Veldhuizen RA; Wan F; Duplan J; Denning L; Possmayer F; Gilpin AA; Yao LJ; Bjarneson D; Lewis JF
Am J Respir Crit Care Med; 1996 Jul; 154(1):98-104. PubMed ID: 8680706
[TBL] [Abstract][Full Text] [Related]
16. A novel continuous powder aerosolizer (CPA) for inhalative administration of highly concentrated recombinant surfactant protein-C (rSP-C) surfactant to preterm neonates.
Pohlmann G; Iwatschenko P; Koch W; Windt H; Rast M; de Abreu MG; Taut FJ; De Muynck C
J Aerosol Med Pulm Drug Deliv; 2013 Dec; 26(6):370-9. PubMed ID: 23421901
[TBL] [Abstract][Full Text] [Related]
17. Overview of surfactant replacement trials.
Suresh GK; Soll RF
J Perinatol; 2005 May; 25 Suppl 2():S40-4. PubMed ID: 15861172
[TBL] [Abstract][Full Text] [Related]
18. Inherited disorders of neonatal lung diseases.
Yurdakök M
Turk J Pediatr; 2004; 46(2):105-14. PubMed ID: 15214737
[TBL] [Abstract][Full Text] [Related]
19. To tube or not to tube babies with respiratory distress syndrome.
Sekar KC; Corff KE
J Perinatol; 2009 May; 29 Suppl 2():S68-72. PubMed ID: 19399013
[TBL] [Abstract][Full Text] [Related]
20. Very early surfactant without mandatory ventilation in premature infants treated with early continuous positive airway pressure: a randomized, controlled trial.
Rojas MA; Lozano JM; Rojas MX; Laughon M; Bose CL; Rondon MA; Charry L; Bastidas JA; Perez LA; Rojas C; Ovalle O; Celis LA; Garcia-Harker J; Jaramillo ML;
Pediatrics; 2009 Jan; 123(1):137-42. PubMed ID: 19117872
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
